Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 30,000 shares at $20.30 ($609K) on 2025-09-08, disclosed to the SEC on 2025-09-10.
Open-market sale of $609k CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-11-29 | $372K | — | Filing → |
| CPRX | SELL | 2024-03-28 | $822K | — | Filing → |